Viral load

A 12 year old boy presents to urgent care with knee swelling and pain. On review of the record, he was seen and diagnosed with strep pharyngitis a month ago. On further questioning, mother admits she was unable to fill his prescription for amoxicillin, but his throat symptoms resolved. History reveals migratory arthritis, intermittent fevers up to 102oF. On physical exam, there are no oral lesions, neck is supple and there is a soft diastolic murmur. His right knee has a small effusion. Which of

On November 10, 2016, a new report was released to the public about a special type of microchip that can test the amount of viral load of HIV in less than 30 minutes. This test can be completely self administered. The user can check the viral load amount in the bloodstream by placing a drop of their blood on the microchip, which looks similar to that of a USB drive. This microchip is then inserted into a computer, tablet, or other handheld device. The results can be achieved in less than 30 minutes

Introduction The African continent represents 12% of the worlds population, but Sub-Saharan Africa disproportionately represents nearly 70% of the worlds HIV cases (1). Within that, it has been estimated that there are 6.1 million people living with HIV/AIDS in South Africa, which is the highest number from any country in the world (2), and represents 17% of the global burden of HIV infection (3). HAART has been the mainstay of treatment for HIV in industrialised countries since the 1990’s (4)

The growth of HIV cases in Indonesia is one of the most rapid ones among the countries in Asia (UNAIDS 2013). Indonesia’s Ministry of Health estimates that more than 500.000 people in Indonesia will become infected with HIV in 2014 unless there is an acceleration of HIV prevention programs (UNICEF Indonesia 2012). In Indonesia, the testing of HIV currently is done in voluntary counseling and testing (VCT) clinics in selected hospitals. The patients are required to visit the clinic to do the testing

According to the Clinical Leadership & Management Review, (2008) healthcare spending is currently taking up 16.2 percent of our nation’s economy. According to the Centers for Medicare and Medicaid Services, cost is expected to rise to twenty percent by 2015. Nearly, seventy percent of medical decisions are based on laboratory tests, yet the costs of lab tests account for only four percent of the total in health care costs. Annual sales for clinical laboratory testing in the U.S. in 2001 were thirty-five

Worldwide, HIV/AIDS poses an enormous challenge on the survival of mankind. HIV is the leading cause of mortality among women of reproductive age worldwide and is a major contributor to maternal, infant and child morbidity and mortality (1). 33.4 million People are estimated to be living with HIV worldwide; 15.7 million are women and 2 million are children younger than 15 years of age (1). With an adult prevalence of 5.2% in 2008, sub-Saharan Africa (SSA) has been the most severely HIV stricken region

testing programs. The Home Access HIV-1 Test System is a home kit that implicates a person’s finger being pricked for a sample of their blood, after the blood is sent to the lab for testing the results would be available on the next available business day. If the results are positive the lab is required to do follow up testing on the blood sample to confirm if the initial HIV result was accurate. The second type of at home HIV testing is the OraQuick In-Home HIV Test, which is used with a swab stick

I. Introduction Human Immunodeficiency Virus (HIV) diagnoses are increasing among women in the United States; as a result there is an increase in newborns born with HIV via vertical transmission, accounting for nearly all pediatric AIDS cases in the US. Between 1999 and 2000, about 370 HIV infected infants were born, 40% of which were born to mothers who were unaware of their HIV status before delivery. Without antiretroviral therapy or other forms of intervention, 25% of infected pregnant women

any undue hardships must be placed upon women who are HIV- negative. Because HIV can be a treatable disease the findings from this study are as most would expect them to be. Early detection leads to an increased likelihood of preventing the viral transmission of the disease. The findings themselves are quite impressive also. If at anytime the spread of a disease can be decreased by nearly 50 % as long as it is detected and treated in a timely fashion, then it is easy to assume that those

introduced in called to reach at least 90% of all people living with the virus to know their HIV status; 90% of all those diagnosed with HIV infection to receive sustain antiretroviral therapy; and 90% of all those initiated the treatment to have viral suppression by the year 2020 (UNAIDS, 2014a). To achieve the diagnosis goal, both client and provider-initiated service deliveries are implemented in various countries to increase access to HIV testing and counselling. Despite these efforts, the uptake